As it was demonstrated that SRSF1 knockdown in C9FTD/ALS Drosophila model blocks neurodegeneration, SRSF1 could be a potential therapeutic target [82]. The gene discussed is SRSF1; the disease is amyotrophic lateral sclerosis.